Interesting facts
Facts About Ozone-Responsive Compound: O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
This compound, featuring a complex molecular structure, is part of a class of compounds known as dihydropyridines. These compounds are known for their fascinating biological activity and potential therapeutic applications. Here are some notable points regarding this compound:
- Biological Significance: Dihydropyridines like this one have been extensively studied for their role as calcium channel blockers. These medications can help in the treatment of conditions such as hypertension and angina.
- Innovative Design: The presence of an ethyl and methyl group along with a chlorophenyl moiety indicates a carefully structured approach to enhance pharmacological properties, potentially increasing the compound's efficacy and selectivity.
- Amino Group Functionality: The aminoethoxymethyl side chain contributes to increased solubility and bioavailability, which are crucial for achieving desired therapeutic effects in a biological system.
- Reactivity Considerations: The dicarboxylate functional groups may offer sites for chemical modification, allowing for the potential derivation of new compounds with tailored characteristics.
- Research and Development: This compound's structural complexities make it a candidate for ongoing research. As scientists explore its interactions within biological systems, this compound could lead to innovative drug development.
In summary, the compound O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate holds promise due to its multifaceted nature. Scientists are continually striving to unlock its full potential, paving the way for advancements in medicinal chemistry.
Synonyms
amlodipine
88150-42-9
Norvasc
Amlocard
Amlodipino
Coroval
Lipinox
AMLODIPINE BASE
Amlodipinum
Amlodipine Free Base
Caduet
Istin
Amlodipinum [Latin]
CHEBI:2668
3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Amlodipine besilate
Amlodis
UNII-1J444QC288
HSDB 7079
HGP0904
UK-4834011
HGP-0904
Norvasc (TN)
CKD-330 COMPONENT AMLODIPINE
MFCD00864687
1J444QC288
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
DTXSID7022596
EC 425-820-1
Amlodipino [Spanish]
88150-42-9 (free base)
Amlodipinum (Latin)
3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Amlodipine [INN:BAN]
AMLODIPINE (MART.)
AMLODIPINE [MART.]
Racemic Amlodipine
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3-Ethyl-5-methyl (+-)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl (+-)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-O-ethyl 5-O-methyl 4-(2-chlorophenyl)-1-deuterio-2-[2-(dideuterioamino)ethoxymethyl]-6-methyl-4H-pyridine-3,5-dicarboxylate
(R)-Amlodipine-d4
3,5-PYRIDINEDICARBOXYLIC ACID, 2-((2-AMINOETHOXY)METHYL)-4-(2-CHLOROPHENYL)-1,4-DIHYDRO-6-METHYL-, 3-ETHYL 5-METHYL ESTER, (+/-)-
3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
SR-05000001461
NCGC00165957-04
Amlodipine 100 microg/mL in Acetonitrile
amlodipina
(RS)-3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
2-[2-aminoethoxymethyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
Amlodipine (Standard)
amlodipine (NORVASC)
AMLODIPINE [MI]
Amlodipine (USP/INN)
AMLODIPINE [INN]
Spectrum2_000486
Spectrum3_001004
Spectrum4_001132
Spectrum5_001550
AMLODIPINE [VANDF]
AMLODIPINE [WHO-DD]
CHEMBL1491
SCHEMBL26478
BSPBio_002727
KBioGR_001643
MLS001401409
AMLODIPINE [EMA EPAR]
BIDD:GT0810
SPBio_000351
DTXCID302596
GTPL6981
AMLODIPINE [ORANGE BOOK]
CHEMBL3211346
CHEMBL3304444
HY-B0317R
KBio3_001947
C08CA01
Copalia (amlodipine + valsartan)
Morphine Sulfate Pentahydrate USP
BCPP000403
HMS2052N03
HMS2089H07
HMS2231K08
HMS3370G17
HMS3394N03
HMS3651I04
HMS3713C10
1346616-97-4
ALBB-027270
BCP02420
HY-B0317
BDBM50088383
s1905
STL356053
AKOS015843475
AC-4535
BCP9000295
CCG-101157
CCG-220414
DB00381
FA61536
NC00407
NCGC00165957-01
NCGC00165957-02
NCGC00165957-03
NCGC00165957-05
NCGC00165957-07
3-Ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
AS-13747
BA164164
CPD000469198
DA-56266
O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
PD003146
PD033068
SMR000469198
SY104813
DB-262294
NS00000043
SW220228-1
C06825
D07450
EN300-708796
AB01209618-01
AB01274726-01
AB01274726-02
AB01274726_03
AB01274726_04
AB01274726_05
Katerzia (amlodipine oral suspension, 1 mg/mL)
Q411347
Katerzia® (amlodipine oral suspension, 1 mg/mL)
SR-05000001461-3
SR-05000001461-4
SR-05000001461-5
BRD-A22032524-001-03-5
BRD-A22032524-001-05-0
BRD-A22032524-074-02-4
BRD-A22032524-074-03-2
BRD-A22032524-074-04-0
BRD-A22032524-074-06-5
BRD-A22032524-074-07-3
BRD-A22032524-074-09-9
2-(2-aminoethoxy)methyl-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methylester
2-[2-Aminoethoxymethyl]-3-ethoxycarbonyl-4-(2-chlorophenyl)-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
3,5-pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, benzene sulfonate
3-ETHYL 5-METHYL (+/-)-2-((2-AMINOETHOXY)METHYL)-4-(O-CHLOROPHENYL)-1,4-DIHYDRO-6-METHYL-3,5-PYRIDINEDICARBOXYLATE
3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate
3-Ethyl 5-methylester, (+-)-2-((2-aminoethoxy)methyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl 5-methylester, (+/-)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylate
3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-ethyl5-methyl2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Solubility of O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
This compound, with the molecular formula C20H25ClN2O5, presents intriguing properties when examining its solubility characteristics. Solubility is a critical aspect that influences the compound's behavior in various applications, particularly in pharmaceuticals and chemical processes.
Factors Influencing Solubility
Several factors determine the solubility of this compound:
Solubility Patterns
Based on structural analysis, we can make some predictions regarding its solubility:
In summary, the solubility of O3-ethyl O5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate is influenced by multiple factors, and a detailed examination of its interactions with solvents will help clarify its practical applications.